HOME >> MEDICINE >> NEWS
Women with rare twin-pregnancy complication

Authors of a research letter in this week's issue of THE LANCET provide evidence to suggest that women with a rare twin-pregnancy disorder are at no more increased risk of malignant disease than women with the disorder who choose to have their pregnancy terminated.

Hydatidiform moles are a pregnancy complication where the fetus fails to develop; instead a tumour forms which may become malignant. Hydatidiform moles arise in about one in 1000 to three in 1000 pregnancies; around 16% become malignant, requiring treatment with chemotherapy. For this reason, hydatidiform moles are removed from the womb when they are diagnosed.

Twin pregnancies with one healthy fetus and one hydatidiform mole are rare (occurring in around 1 in 20,000-100,000 twin pregnancies); women are usually advised to have the pregnancy terminated and the hydatidiform mole removed, to reduce the risk of malignant disease. Some women are reluctant to accept this advice.

Michael Seckl and colleagues from Imperial College School of Medicine, London, UK, assessed 77 such twin pregnancies to establish the risks to the mother and baby of continuing the pregnancy compared with termination. 24 women with a hydatidiform mole and healthy fetus decided to have a termination. 53 women continued with their pregnancies, though two had to have terminations because of severe pre-eclampsia, and 23 had a spontaneous aborted. 28 pregnancies lasted 24 weeks or more, resulting in 20 livebirths. Chemotherapy to treat malignant disease was required in three of 19 women (16%) who chose to have a termination and in 12 of 58 (21%) who did not.

Edward Newlands (one of the investigators) comments: "Our findings, therefore, suggest that women with twin pregnancies complicated by a hydatidiform mole who wish to continue their pregnancy, have a 40% chance of a successful outcome. Moreover, this choice is associated with a relatively small chance of serious obstetric complications and does not seem t
'"/>

Contact: Richard Lane
richard.lane@lancet.com
44-207-424-4949
Lancet
20-Jun-2002


Page: 1 2

Related medicine news :

1. The European Society of Cardiology launches Women at Heart
2. Women less likely to get quality heart attack care
3. Statement on the findings of the Womens Health Study
4. Women should be advised not to drink alcohol in pregnancy
5. Women with thyroid problem have lower risk of breast cancer
6. Women successfully treated to prevent preterm labor at low risk for recurrent episode
7. Womens heart risk underestimated by doctors, resulting in less preventive care than in men
8. Women, drinking to their health
9. Women want annual pap smears
10. Women In Government report on eliminating cervical cancer
11. Women need less morphine after hysterectomies with new treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Southern ... and Jennifer Huggins, PharmD ’17, along with clinical associate professor Janice Frueh, ... cardiovascular diseases during the 15th Annual Women’s Health Conference. The SIU School ...
(Date:10/13/2017)... SAN LUIS OBISPO, Calif. (PRWEB) , ... October 13, 2017 , ... ... with Alzheimer’s or dementia. However, many long-term care insurance companies have a waiver for ... mean is the 90-day elimination period, when the family pays for care, is often ...
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th Annual ... in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, Jon ... fun run is geared towards children of all ages; it is a non-competitive, non-timed ...
(Date:10/13/2017)... VA (PRWEB) , ... October 13, 2017 , ... ... of DevOps and Agile Software Development, has been awarded a contract by the ... Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile methodologies ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
Breaking Medicine News(10 mins):
(Date:9/25/2017)... R.I. , Sept. 25, 2017  EpiVax, ... assessment, vaccine design, and immune-engineering today announced the ... on the development of personalized therapeutic cancer vaccines. ... has provided exclusive access to enabling technologies to ... Eng., MBA will lead EpiVax Oncology as Chief ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
(Date:9/13/2017)... ATLANTA , Sept. 13, 2017   OrthoAtlanta ... to the Atlanta Football Host Committee (AFHC) for the 2018 ... Monday, Jan. 8, 2018, at Mercedes-Benz Stadium in ... part of the AFHC "I,m In" campaign, participating in many ... ...
Breaking Medicine Technology:
Cached News: